Rheos Capital Works Inc. Edwards Lifesciences Corp Transaction History

Rheos Capital Works Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$69.28 - $93.38 $6.93 Million - $9.34 Million	100,000 Added 63.23%	258,165 $17.9 Million
Q1 2023 May 02, 2023	SELL	$74.26 - $84.51 $1.63 Million - $1.86 Million	-22,000 Reduced 12.21%	158,165 $13.1 Million
Q2 2021 Jul 26, 2021	BUY	$83.84 - $104.76 $2.1 Million - $2.62 Million	25,000 Added 16.11%	180,165 $18.7 Million
Q1 2021 Apr 26, 2021	BUY	$78.68 - $90.67 $1.57 Million - $1.81 Million	20,000 Added 14.8%	155,165 $13 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $5.52 Million - $7.38 Million	95,910 Added 244.33%	135,165 $9.34 Million
Q1 2020 Apr 20, 2020	BUY	$52.41 - $81.0 $2.06 Million - $3.18 Million	39,255 New	39,255 $7.4 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Rheos Capital Works Inc., based on Form 13F filings with the SEC.

Stay updated on Rheos Capital Works Inc. with notifications on news.